← Eichor
Study identifier: NCT04522193 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Dumping Syndrome and Esophageal Atresia

Condition: Oesophageal Atresia · Dumping Syndrome  ·  Sponsor: University Hospital, Lille

PhaseNA
Planned participants15
Who can joinAll sexes, 2 Months to 3 Months
Healthy volunteersNo

About this study

Dumping syndrome (DS) is frequent in oesophageal atresia (29%). In causing hypoglycaemia, it can be dangerous for neonates. Mechanisms of DS are actually partialy understood. This is also an affection difficult to diagnose, because it only occurs after meals and can be inconstantly present. To date, their is only symptomatic treatment for DS. This study aims to understand its pathological mechanisms so as to better treat it and avoid its consequences. Oesophageal atresia patients enrolled in this study will benefit from a continuous glycemic monitoring, a continuous cardiac monitoring, and an a gastric emptying scintigraphy at the age of 3 months

This description comes directly from the study's public registry record.

Talk to the study team

Madelaine AUMAR, MD  ·  0320445962  ·  madeleine.aumar@chru-lille.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Hôpital Jeanne de FlandresLille, FranceNot Yet Recruiting
Hôpital Jeanne de Flandre - Pôle enfant, CHU de LilleLille, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04522193